Pillstats
Rx only · Tablet, Film Coated · Oral

Indapamide

Indapamide

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)5764
US makers7 labelers
Packages25
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.032$0.065$0.097$0.129Dec 2025Apr 2026Jul 2026
$0.108
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
7
Active US suppliers
56%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.8K9.7K14K19K2025 Q12025 Q22025 Q32025 Q42026 Q1
16K
Rx · 2026 Q1
763K
Units dispensed
-4%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Actavis Pharma, Inc.unknown8SUPPLYING
Bryant Ranch Prepackrepackager6SUPPLYING
Preferred Pharmaceuticals Inc.unknown4SUPPLYING
Golden State Medical Supply, Inc.unknown2SUPPLYING
ANI Pharmaceuticals, Inc.unknown2SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING
Direct_Rxunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.